For dentists, periodontists, and oral surgeons
Add evidence-based peptide education to your practice, with confidence.
Patients are already asking about peptides after extractions, implants, and perio surgery. PeptIQ.io gives your team one cited answer: what has actually been studied in the mouth, how strong that evidence is, and what FDA status applies. Then it keeps patients on protocol between visits.
67 verified studies across 24 peptides and biologics. Education only; PeptIQ.io does not sell or dispense peptides.
Three problems dental teams tell us about
Uncertain evidence and legality
A patient asks about BPC-157 after an extraction. Is there a study? Is it legal to even discuss? Most practices have no fast, cited answer, so the conversation ends in a shrug or a guess.
Patient questions nobody owns
The front desk hears it first, the hygienist second, the dentist last. Without a shared, sourced reference, every answer is a different answer, and some of them are claims.
Follow-through after procedures
Post-operative instructions, rinses, reminders, and check-ins live on paper. Once the patient leaves, adherence is invisible until the next visit, if there is one.
How PeptIQ.io helps a dental practice
Cited evidence in two places at once: the patient app, where patients read it, and the provider console, where your team assigns protocols and watches follow-through. The console never changes a regulatory light or makes a clinical decision. It makes the program you can legally offer actually stick.
Cited evidence, everywhere
The same evidence grade and FDA status a dentist sees in the console is what the patient sees in the PeptIQ app. Every statement points at a PubMed record or an FDA page.
Assign a protocol in the console
Publish a post-procedure or maintenance protocol once, then assign it per patient. Phases, schedules, and instructions live in one place your staff can read.
Patient education with sources attached
Patients read what was studied, in whom, and what the authors reported, in plain English. No treatment claims, no dosing, and the citation is one tap away.
Reminders between visits
The patient app nudges on schedule so instructions do not depend on a paper handout surviving the drive home.
Adherence you can see
Scheduled versus logged, per patient, with a flag when someone slips. You find out this week, not at the six-month recall.
Refill and re-check nudges
When a patient is about to run out or is due for a check, the roster says so. Clinical decisions stay with the prescriber; the console just keeps the loop closed.
What the dental evidence actually looks like
Two axes, read separately. Evidence strength is the best study type we could verify for a dental use. The regulatory light is the same one used across the PeptIQ.io provider hub. Approved biologics have human trials. The compounded peptides patients ask about mostly do not.
Ready to prescribe. FDA-approved or cleared finished product.
Possible with conditions. Not an approved finished product, or compounding is contested.
Don't touch. Investigational, barred from compounding, or research-only supply.
| Peptide | Best dental evidence | Regulatory |
|---|---|---|
| Enamel matrix derivative (Emdogain)At least one randomized controlled trial in people, or a systematic review of such trials, for this dental use. | Human RCT | Ready to prescribe |
| Self-assembling peptide P11-4 (Curodont)At least one randomized controlled trial in people, or a systematic review of such trials, for this dental use. | Human RCT | Ready to prescribe |
| rhPDGF-BB (GEM 21S)At least one randomized controlled trial in people, or a systematic review of such trials, for this dental use. | Human RCT | Ready to prescribe |
| Teriparatide (Forteo, PTH 1-34)At least one randomized controlled trial in people, or a systematic review of such trials, for this dental use. | Human RCT | Ready to prescribe |
| BPC-157Human data exists but is observational, small, uncontrolled, or early-phase. Suggestive, not settled. | Human limited | Possible with conditions |
| TB-500 / thymosin beta-4Human data exists but is observational, small, uncontrolled, or early-phase. Suggestive, not settled. | Human limited | Possible with conditions |
| GHK-CuWe searched PubMed and ClinicalTrials.gov and found no dental or oral study. Absence of evidence, stated plainly. | None | Possible with conditions |
| KPVRat, mouse, dog, or pig models only. Nothing here tells you what happens in a patient. | Animal | Possible with conditions |
Free for dental teams
PeptIQ.io Dental Peptide Evidence Guide
A letter-size PDF for the dentist, the periodontist, and the front desk: five use-case tables, every study with its PubMed link, and the FDA status behind each peptide. Unlocking also opens the per-study detail on the web guide and the rest of the provider hub.
- Periodontal, bone and implants, oral mucosa, extraction healing, enamel
- Human RCT vs animal vs lab, labeled honestly
- FDA status and quote for every peptide
- How the provider console fits a dental practice
Work email. Takes ten seconds.
Questions dental practices ask
- Does PeptIQ.io sell or recommend peptides to dental practices?
- No. PeptIQ.io is education and tracking software. It does not sell, source, or dispense peptides, and it does not tell a prescriber what to prescribe. It shows what has been studied, how strong that evidence is, and what FDA status applies, with citations.
- Is there real dental evidence for the peptides patients ask about?
- For FDA-regulated biologics such as enamel matrix derivative, rhPDGF-BB, and the P11-4 self-assembling peptide, yes: randomized trials and meta-analyses exist. For the compounded peptides patients usually mean, such as BPC-157 and TB-500, the dental literature is animal and laboratory work only. The evidence guide shows both, graded, and says so plainly.
- Who is this for?
- General dentists, periodontists, oral and maxillofacial surgeons, and the practice managers and front-desk teams who field the questions. It is also useful for a dental practice that already works with a prescribing physician on adjunctive care.
- What does the walkthrough cover?
- Twenty minutes on the provider console: how a protocol is assigned, what a patient sees in the app, how education shows its sources, and how adherence and refill timing appear on the roster. No slides about peptides, no sales deck.
Looking for the general provider hub? Provider resources and compound status.
See the console with a dental protocol loaded.
Twenty minutes. We assign a post-procedure protocol, show what the patient sees in the app with the sources attached, and open the adherence roster. If it does not fit your practice, you will know by minute ten.
Education only. PeptIQ.io does not sell, source, or dispense peptides, and nothing here is a treatment recommendation. Clinical decisions belong to licensed prescribers working with their pharmacy, their counsel, and their state boards. No dosing is included or implied. Study summaries describe what was studied and what the authors reported, not what any product does for a patient.